By Betty Zou Daniel Drucker (MD ’80, PGME ’84) is at the pinnacle of his career. Glucagon-like peptide-1 (GLP-1) medicines, such as Ozempic and Wegovy, are everywhere and are having a massive cultural moment thanks in part to Drucker, a professor at the University of Toronto’s Temerty Faculty of Medicine. Starting in the 1980s, he didContinue reading “Instinct for Integrity”